Novotech Appoints Anand Tharmaratnam

Novotech, a globally recognized full-service biotech clinical research organization (CRO), is pleased to announce the appointment of Dr. Anand Tharmaratnam as its new Chief Executive Officer. Dr. Tharmaratnam brings nearly three decades of experience in the global CRO industry and has served as Novotech Chairman since 2021. He commenced as Chairman and CEO on 1 […]

Benchling and Lilly TuneLab Partner to Democratize Access to AI Models for Scientists Everywhere

Benchling, the platform for scientific progress, announced a strategic collaboration with Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform created by Eli Lilly and Company (Lilly) to provide access to models trained on decades of Lilly’s proprietary research data, representing over $1 billion in research investment. Through this program, Lilly is extending TuneLab’s […]

Sharp Sterile Manufacturing increases capacity with $28 million investment

Sharp Sterile Manufacturing has announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art facility will strengthen opportunities for highly skilled engineering and pharmaceutical manufacturing roles within the local life sciences community and represents a major milestone in Sharp Sterile’s development. The Lee facility, which has been in operation since 2014, […]

FUJIFILM Irvine Scientific Now Officially FUJIFILM Biosciences

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the life science market, today announced the Company has officially changed its legal name from FUJIFILM Irvine Scientific, Inc., to FUJIFILM Biosciences Inc., effective January 1, 2026. The FUJIFILM Biosciences’ name builds upon the Company’s roots as a pioneer in […]

Qureight appoints Dr Steven Bishop as Chief Medical Officer

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered CT imaging biomarkers and clinical data management platform in clinical trials, today announced the appointment of Dr Steven Bishop as Chief Medical Officer (CMO). Previously Chief Data Officer, Steven’s new role reflects changes in company structure, in response […]

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through its benchtop eProtein Discovery™ System, today announced that it has completed the first installations of eProtein Discovery in Asia, with systems now operational at the Department of Pharmacy and the Department of Chemistry at the National Taiwan University (NTU) […]

Pharmapack 2026 to return to Paris with focus on GLP-1 innovation and sustainable packaging

Pharmapack by Informa Markets, Europe’s leading event for pharmaceutical packaging and drug delivery, will return to Paris Expo Porte de Versailles on January 21–22, 2026, bringing together global pharma, packaging and device leaders for two days of insight and innovation. Now in its 25th year, Pharmapack will welcome more than 6,000 attendees from 90 countries, […]

mAbxience and Amneal Announce FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®

mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, and Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”), announced that the U.S. Food and Drug Administration (FDA) has approved its Biologics Licensing Applications (BLAs) for Boncresa™ (denosumab-mobz), a biosimilar referencing Prolia®, and Oziltus™ (denosumab-mobz), a biosimilar referencing XGEVA®. Denosumab is a monoclonal antibody […]

Symbiosis begins commercial manufacturing at new FDA-inspected facility

Symbiosis Pharmaceutical Services (Symbiosis), a leading sterile fill finish contract manufacturing organisation (CMO), has manufactured their first 10,000 vial batch at the company’s new facility in Stirling, UK. The project, delivered for one of Symbiosis’ long-standing clients, supports the development of a cancer immunotherapy currently in Phase III trials This production batch of 10,000 vials […]